Full-Time

Director – Engineering

Drug Product

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Norwood, MA, USA

70% in-office work model.

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s or Master’s degree in Engineering or a related technical field; advanced degree preferred.
  • At least 15 years of experience in engineering roles within the pharmaceutical industry, specifically with drug product manufacturing equipment such as filling, packaging, and labeling systems.
Responsibilities
  • Lead the development of a Technical Authority organization to support manufacturing operations and provide expert guidance on engineering decisions for drug product processes globally.
  • Act as the Global Subject Matter Expert (SME) in primary and secondary packaging, filling, labeling, and closing equipment, and processes.
  • Establish and maintain best practices and functional standards that enable global standardization of engineering processes, equipment, and systems.
  • Lead the Front End Planning (FEP) for capital projects, including scope determination, design review, manufacturability assessments, cost analysis, risk evaluation, and schedule planning.
  • Oversee and participate in the complete project lifecycle, including conceptual design, procurement, construction, installation, start-up, commissioning, validation, and qualification of equipment.
  • Ensure project documentation is accurate, comprehensive, and compliant with regulatory and internal standards, including URS, functional descriptions, and engineering drawings.
  • Develop and own specifications for filling, labeling, and packaging equipment, leading the selection and assessment of equipment vendors.
  • Collaborate with cross-functional teams to define user requirements, design specifications, and process parameters, providing input into risk assessments (FMEA) and operational strategies.
  • Drive the development of Engineering Turnover Packages, ensuring accurate documentation, operating manuals, and GMP compliance for all process equipment.
  • Ensure that all global manufacturing processes comply with regulatory requirements (e.g., GMP, FDA, EMA), including validation and qualification activities.
  • Lead Factory Acceptance Testing (FAT), Site Acceptance Testing (SAT), and commissioning of equipment at vendor locations and on-site.
  • Support global qualification strategies, including vision systems for Automated Visual Inspection (AVI), and troubleshooting equipment failures while ensuring preventive maintenance and continuous improvement.
  • Drive innovation by identifying new technologies for filling and closing equipment, primary and secondary packaging, and vision inspection systems.
  • Lead testing and evaluation of new technologies to support the global technical roadmap, providing solutions for emerging business needs and continuous process improvements.
  • Act as a technical influencer, providing guidance to senior leadership on business initiatives and strategic capital investments.
  • Serve as a problem solver for complex engineering challenges, troubleshooting equipment, determining root causes of failures, and driving preventive maintenance initiatives.
  • Support deviation investigations, change controls, and regulatory audits by providing expertise in process equipment and compliance.
  • Lead the creation and optimization of machine recipes, and support re-qualification and inspections as needed across global sites.
  • Develop and maintain global training standards for technicians and engineering teams, ensuring best practices are followed across all facilities.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?